Your Recent Quotes: 0 | 0

Johnson & Johnson

Related Information and Financials
Price Glossary Definition
68.66
0.57%
7/24/08 4:01
Open
68.26
Prev Close
68.27
Volume
16,440,870
52 Wk. Range
60-69
Year-to-Date Performance Glossary Definition
Latest Dividend
Dividend
0.46
Yield
2.71
Ex-Date
08/22/2008
Price/Earnings Comparisons Glossary Definition
 
16.30
 
16.20
 
17.50
JNJ
Sect. Av.
S&P 500
Market Cap
191,608,874,100
Outstanding Shares
2,829,779,000
TheStreet Rating Glossary Definition
  • A
  • B
  • C
  • D
  • E
Buy JNJ Rating Report
Target Price (1Yr)
High
80.00
Revenue
65.21B

Annual Dividend
Rate
1.84
Yield
2.70
Growth
12 Month
3 Year
CAGR
Revenue
14.60
0.29
0.09
Net Income
-4.30
0.24
0.07
EPS
-2.70
0.28
0.08

Stock Performance History
 
3 Month
1 Year
3 Year
Price Change
1.49
10.49
5.71
Earnings Per Share($)

12/2005
 
 
 
3.50
12/2006
 
 
 
3.76
12/2007
 
 
 
3.67

Earnings
EBITDA
17.99B
Revenue
61.10B
Outside Analyst Rating History

7/24/08
9
Buy
7/24/08
4
Hold
7/24/08
0
Sell

Jim Cramer Portfolio
Find out now if JNJ is in Jim's personal portfolio at Action Alerts PLUS.
Compare This Stock
  • S&P 500 (SPX.X)
  • Dow Jones (INDU)
  • Nasdaq (COMPX)
    Latest Headlines
    People are spending more on their newborns all the time, and the skin-care industry has taken notice.

    10:15AM 07/24/08

    The bears are never right for long, and there are plenty of stocks out there worth buying.

    10:03AM 07/24/08

    The Mad About Options crew reviews Jim Cramer's recent bearish comments about Apple and the tech industry and offers options strategies for traders and investors. Also hear options ideas for 3M and OshKosh.

    08:59PM 07/23/08

    Watch Video
    Video
    The company was able to expand itself without diluting its brand. Your small biz can apply this strategy, too.

    11:02AM 07/18/08

    These are some of the stocks Cramer's been talking about lately.

    6:59AM 07/18/08

    The trading panel says it was down about 7% after lowing its third-quarter guidance.

    7:22PM 07/16/08

    The drugmaker is seeking FDA approval for expanded use of Doribax, as treatment for hospital-acquired pneumonia.

    5:36PM 07/16/08

    Johnson & Johnson is among the most-searched stocks on TheStreet.com. Here's what Cramer had to say about it recently.

    11:07AM 07/16/08

    The trading panel gives good reviews to GM's turnaround plan.

    6:44PM 07/15/08

    The blue-chip indices falter Tuesday, and the Dow ends below the 11,000 mark. The Nasdaq, however, edges higher. Oil prices take a sharp tumble.

    4:12PM 07/15/08

    Understanding the Market

    Our Experts' Take at RealMoney
    The stock continues it's pattern of dipping to than jumping off of its 200-day moving average.

    3:59PM 07/24/08

    Seeking salvation down deep as I continue to prove my earnings plays leave something to be desired.

    3:31PM 07/24/08

    More Experts' Takes


    Premium Stock Ideas
    Is Cramer trading JNJ in his Action Alerts Plus Portfolio?